Rivaroxaban for cancer-associated cardiac thrombosis

Am J Med. 2015 Oct;128(10):e43-4. doi: 10.1016/j.amjmed.2015.05.031. Epub 2015 Jun 11.

Authors

Marcello Di Nisio¹, Consiglia Carella², Clara Natoli², Ettore Porreca³, Michele De Tursi²

Affiliations

¹ Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy. Electronic address: mdinisio@unich.it.
² Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy.
³ Department of Medicine and Ageing Sciences, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy.

PMID: 26071831
DOI: 10.1016/j.amjmed.2015.05.031

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Carcinoma / complications
Factor Xa Inhibitors / therapeutic use*
Heart Diseases / drug therapy*
Heart Diseases / etiology
Humans
Kidney Neoplasms / complications
Male
Middle Aged
Rivaroxaban / therapeutic use*
Thrombosis / drug therapy*
Thrombosis / etiology

Substances

Factor Xa Inhibitors
Rivaroxaban